Skip to content

Depression patients' sleep EEG power spectral density and suicide correlation study

Depression patients' sleep EEG power spectral density and suicide correlation study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106660
Enrollment
Unknown
Registered
2025-07-28
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

The group with suicidal ideation:None
The group without suicidal ideation:None
Healthy control group:None

Sponsors

Xianyang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with depression: Aged between 18 and 65 years old; meeting the diagnostic criteria for depressive episode (including first-episode and recurrent depressive disorder patients) in the 10th edition of the International Classification of Diseases (ICD-10); the total score of the Hamilton Depression Rating Scale (HAMD) > 17; being of Han ethnicity; all participants not taking psychiatric or sleep medications for at least 2 weeks; avoiding alcohol and drug use 2 weeks before the start of the study; participants maintaining a regular sleep schedule for at least 5 days before polysomnography (PSG) and completing a sleep diary; fully understanding the polysomnography monitoring method and safety, being willing to actively cooperate with the test, and signing the informed consent form. Healthy control group: age 18-65 years; Healthy people without major physical or mental illness; fully understand the method and safety of cerebral polysomnography, and be willing to actively cooperate with the test and sign the informed consent form.

Exclusion criteria

Exclusion criteria: Suffering from disorders of consciousness, mental retardation, brain trauma, and other mental illnesses; organic psychosis, history of epilepsy and family history of epilepsy; depression caused by other psychoactive substances and non-addictive substances; use of anti-epileptic drugs, such as valproate, carbamazepine, etc.; abnormal thyroid function, nervous system diseases; pregnant women and lactating women; individuals with a strong suicidal intention in the acute phase who need to be immediately referred for clinical intervention.

Design outcomes

Primary

MeasureTime frame
a- wave power spectral density;

Secondary

MeasureTime frame
ß - wave power spectral density;?- wave power spectral density;d wave power spectral density;?- wave power spectral density;

Countries

China

Contacts

Public ContactBang An

Xianyang Central Hospital

xyanbang@163.com+86 138 9109 5228

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026